INTELLI PROGEN Trademark

Trademark Overview

On Wednesday, November 25, 2020, a trademark application was filed for INTELLI PROGEN with the United States Patent and Trademark Office. The USPTO has given the INTELLI PROGEN trademark a serial number of 90343139. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 25, 2023. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The INTELLI PROGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

product development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; biochemical research and analysis; research services for biomedical science; pharmaceutical preparations and medicines development; research and development of antibodies
intelli progen

General Information

Serial Number90343139
Word MarkINTELLI PROGEN
Filing DateWednesday, November 25, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 25, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements

Pseudo MarkINTELLIGENT PRO GEN
Goods and Servicesproduct development for others; pharmaceutical drug development services; scientific research and development; pharmaceutical research; research and development of new products; Consulting services in the field of pharmaceutical technology development; biochemical research and analysis; research services for biomedical science; pharmaceutical preparations and medicines development; research and development of antibodies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 1, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDUNDALK, COUNTY LOUTH A91X56F
IE
Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDUBLIN 1
IE

Trademark Events

Event DateEvent Description
Tuesday, December 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 25, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, April 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023SOU EXTENSION 3 GRANTED
Monday, April 17, 2023SOU EXTENSION 3 FILED
Monday, April 17, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2022SOU EXTENSION 2 GRANTED
Friday, October 28, 2022SOU EXTENSION 2 FILED
Friday, October 28, 2022SOU TEAS EXTENSION RECEIVED
Saturday, April 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 28, 2022SOU EXTENSION 1 GRANTED
Thursday, April 28, 2022SOU EXTENSION 1 FILED
Thursday, April 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 1, 2021NON-FINAL ACTION E-MAILED
Tuesday, June 1, 2021NON-FINAL ACTION WRITTEN
Tuesday, May 11, 2021ASSIGNED TO EXAMINER
Monday, February 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 28, 2020NEW APPLICATION ENTERED

Related Keywords

progen intelli development research pharmaceutical services biomedical analysis science antibodies biochemical preparations